PMID- 34279713 OWN - NLM STAT- MEDLINE DCOM- 20220602 LR - 20220814 IS - 1435-2451 (Electronic) IS - 1435-2443 (Print) IS - 1435-2443 (Linking) VI - 407 IP - 3 DP - 2022 May TI - Simultaneous pancreas and kidney transplantation for end-stage kidney disease patients with type 2 diabetes mellitus: a systematic review and meta-analysis. PG - 909-925 LID - 10.1007/s00423-021-02249-y [doi] AB - PURPOSE: The indications for patients with type 2 diabetes mellitus (T2DM) combined with end-stage kidney disease (ESKD) undertaking simultaneous pancreas and kidney transplantation (SPK) remain an unresolved issue. This study aimed to systematically review the survival outcomes of SPK among T2DM-ESKD patients. METHODS: Online databases including PubMed, MEDLINE, EMBASE, and the CENTRAL Library, CNKI, Chinese Biomedical Literature Database, and Wan-Fang database were used to locate the studies of ESKD patients with T2DM undertaking SPK up to May 2021. A third reviewer was consulted if there were disagreements. Data were analyzed with STATA (15.0). RESULTS: Nine cohort studies were identified. The pooled 1-year, 3-year, and 5-year patient survival rates of patients with T2DM and ESKD after SPK were 98%, 95%, and 91% respectively. Comparing the treatment effect of SPK between type 1 diabetes mellitus (T1DM) and T2DM, the survival estimates were comparable. For T2DM patients, SPK had a survival advantage compared with KTA. CONCLUSIONS: The synthesized clinical outcomes of T2DM patients with ESKD after SPK were relatively better than KTA, but a subset of T2DM-ESKD patients who would benefit the most from SPK was to be defined. PROSPERO registration number CRD42019118321. Date of registration: 14 Jan 2019 (retrospectively registered). CI - (c) 2021. The Author(s). FAU - Cao, Yu AU - Cao Y AD - Department of Kidney and Pancreas Transplantation, Tianjin First Central Hospital, Tianjin, China. FAU - Liu, Xiaoli AU - Liu X AD - Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China. FAU - Lan, Xiangyu AU - Lan X AD - Department of Kidney and Pancreas Transplantation, Tianjin First Central Hospital, Tianjin, China. FAU - Ni, Kaiwen AU - Ni K AD - Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China. FAU - Li, Lin AU - Li L AD - Department of Kidney and Pancreas Transplantation, Tianjin First Central Hospital, Tianjin, China. FAU - Fu, Yingxin AU - Fu Y AUID- ORCID: 0000-0001-8010-224X AD - Department of Kidney and Pancreas Transplantation, Tianjin First Central Hospital, Tianjin, China. yingxinfu@nankai.edu.cn. LA - eng GR - NO.8197033298/Major Research Plan/ GR - NO.ZC20167/Tianjin Municipal Health Bureau/ GR - NO.RC20090/Tianjin Municipal Health Bureau/ PT - Journal Article PT - Meta-Analysis PT - Systematic Review DEP - 20210719 PL - Germany TA - Langenbecks Arch Surg JT - Langenbeck's archives of surgery JID - 9808285 SB - IM MH - *Diabetes Mellitus, Type 2/complications/surgery MH - Graft Survival MH - Humans MH - *Kidney Failure, Chronic/complications/surgery MH - *Kidney Transplantation/adverse effects MH - Pancreas MH - *Pancreas Transplantation PMC - PMC9151548 OTO - NOTNLM OT - Kidney transplantation alone OT - Meta-analysis OT - Simultaneous pancreas and kidney transplantation OT - Survival outcomes OT - Type II diabetes COIS- The authors declare no competing interests. EDAT- 2021/07/20 06:00 MHDA- 2022/06/03 06:00 PMCR- 2021/07/19 CRDT- 2021/07/19 13:01 PHST- 2021/04/15 00:00 [received] PHST- 2021/06/13 00:00 [accepted] PHST- 2021/07/20 06:00 [pubmed] PHST- 2022/06/03 06:00 [medline] PHST- 2021/07/19 13:01 [entrez] PHST- 2021/07/19 00:00 [pmc-release] AID - 10.1007/s00423-021-02249-y [pii] AID - 2249 [pii] AID - 10.1007/s00423-021-02249-y [doi] PST - ppublish SO - Langenbecks Arch Surg. 2022 May;407(3):909-925. doi: 10.1007/s00423-021-02249-y. Epub 2021 Jul 19.